• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS FT4, FREE THYROXINE; RADIOIMMUNOASSAY, FREE THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS FT4, FREE THYROXINE; RADIOIMMUNOASSAY, FREE THYROXINE Back to Search Results
Catalog Number 06437281190
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 07/11/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(4).(b)(6).
 
Event Description
The customer received questionable thyroid results for three samples from one patient from a cobas 8000 e 602 module (b)(4).The samples were also tested on a siemens centaur and then submitted for investigation and tested on a cobas 8000 e 602 module.Of the data provided only the results for elecsys ft4 ii assay and elecsys tsh assay were discrepant.Refer to the attachment to the medwatch for all patient data.The results were reported outside of the laboratory.The physician suspected if there was cross-reactivity with the medications.It was noticed the patient's ft3 and ft4 results increased after oral administration of tirononin.On (b)(6) 2017 the patient was prescribed chirazin.On (b)(6) 2017, the patient stopped taking the medication for several days.On (b)(6) 2017 the patient was given thyronamine (t3 formulation).There was no allegation of an adverse event.A specific root cause could not be identified.From the data provided, a general reagent issue could be excluded.The differences in results between the roche and siemens platforms are most likely due to the fact that assays from different vendors can generate different values.This relates to the overall setups of the assays, the antibodies used, and differences in reference materials, and the standardization methodology used.As the exact composition of the medication (thyronamine) given to the patient was not known, cross-reactivity could not be excluded.It was possible that a clinical effect occurred in the patient which could explain the results.(b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FT4, FREE THYROXINE
Type of Device
RADIOIMMUNOASSAY, FREE THYROXINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key7132941
MDR Text Key95905274
Report Number1823260-2017-03038
Device Sequence Number1
Product Code CEC
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K961489
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial
Report Date 12/20/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number06437281190
Device Lot NumberAKSU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/11/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-